$NBIS

Boroditsky Marc sold $1.5M of NBIS

Boroditsky Marc (Chief Revenue Officer) sold 7,000 shares of Nebius Group N.V. (NBIS) at $211.23 ($1.48M total) on 2026-10-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Boroditsky Marc
Published Oct 13, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Bearish
medium confidence
Mentioned
$NBIS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISBearishLow
01

Why it matters

The filing provides the first public disclosure of the CRO's complete exit from Nebius Group shares.

02

Market read

A C‑level insider fully divested holdings, which may be interpreted as a negative signal by the market.

03

What to watch

No disclosed reason for the sale; the 10b5‑1 plan may have been pre‑scheduled, reducing informational value.

Relevance 5/10Novelty 4/10Timing: after-hours filing today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$NBISBearishMedium confidence
Context

Chief Revenue Officer Marc Boroditsky sold 7,000 shares for $1.48 M via a 10b5‑1 plan, reducing his stake to zero.

Expected impact

likely modest downward pressure as the market prices the insider divestment

Evidence & confidence

C‑level insider sales, even modest, are watched by traders; the $1.5 M size is material for a mid‑cap but not large enough to drive a major move.

Market effects

None significant; the sale is company‑specific.

Limited to investors tracking Nebius Group.

Low

Counterpoint

The sale could be a routine liquidity event unrelated to fundamentals, so the stock may remain stable.

Key entities

  • Nebius Group N.V.

    Issuer of the shares sold.

  • Marc Boroditsky

    Chief Revenue Officer and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.